Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Deutsche Medizinische Wochenschrift (1946)|August 23, 2021
[Complaints and clinical findings six months after COVID-19: outpatient follow-up at the University Medical Center Freiburg]Dietrich August, Katarina Stete, Hanna Hilger, et al.
Diabetes, Obesity & Metabolism|March 3, 2023
Identification of predictive factors of diabetic ketoacidosis in type 1 diabetes using a subgroup discovery algorithmAngela Ibald-Mulli, Jochen Seufert, Julia M Grimsmann, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2012
Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PETH Christian Rischke, Matthias R Benz, Damian Wild, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomasDamian Wild, Emanuel Christ, Martyn E Caplin, et al.
Diabetes, Obesity & Metabolism|June 28, 2018
Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add-on to metformin in patients with type 2 diabetesDirk Müller-Wieland, Monika Kellerer, Katarzyna Cypryk, et al.
European Journal of Endocrinology|April 12, 2018
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder formsDaniel A Heinrich, Christian Adolf, Lars C Rump, et al.
BMJ Open Diabetes Research & Care|July 29, 2020
The DIVE/DPV registries: evolution of empagliflozin use in clinical practice in GermanyPeter Bramlage, Sascha R Tittel, Christian Wagner, et al.
Diabetes/Metabolism Research and Reviews|December 28, 2020
The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DMEric Renard, Hiroshi Ikegami, André Gustavo Daher Vianna, et al.
Diabetes, Obesity & Metabolism|March 24, 2018
Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control studyKatharina Laubner, Nina Riedel, Katharina Fink, et al.
Pageof 15